Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
IMMUCOR INC Add to My Watchlist (NSDQ: BLUD) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Immucor 18.71 +0.04 (+0.21%) 667,414
3130 Gateway Drive
P.O. Box 5625
Norcross, GA 30091-5625 US
(770) 441-2051
(770) 441-3807 fax
www.immucor.com
CEO Dr. Gioacchino DeChirico
Auditor Grant Thornton LLP
Exchange Traded NQ
ISIN Number US4525261065
CIK Number 736822
NAICS Code 325412
Business Summary
The Company develops, manufactures and sells a complete line of reagents and automated systems used by hospitals, clinical laboratories and blood banks in tests performed to detect and identify certain properties of human blood.
Number of Employees 729
Share Fundamentals
Market Cap 1.31B
Shares Outstanding 69.86M
Float 69.53M
Short Interest 3.70M
Financial Strength
Revenue (TTM) $319,991,000
Earnings (TTM) $79,924,000
Quick Ratio 4.7:1
Current Ratio 5.9:1
Total Debt/Equity 0:1
Profitability
Gross Margin 74.2%
EBITDA Margin 43.0%
Profit Margin 38.5%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs